We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Pulmatrix Inc is a clinical-stage biotechnology company. The company is focused on the discovery and development of novel inhaled therapeutic products intended to prevent and treat respiratory diseases and infections with significant unmet medical needs. Pulmatrix designs and develops inhaled therap... Pulmatrix Inc is a clinical-stage biotechnology company. The company is focused on the discovery and development of novel inhaled therapeutic products intended to prevent and treat respiratory diseases and infections with significant unmet medical needs. Pulmatrix designs and develops inhaled therapeutic products based on its proprietary dry powder delivery technology, iSPERSE (inhaled Small Particles Easily Respirable and Emitted), which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. The iSPERSE powders are engineered to be small, dense particles with dispersibility and delivery to airways. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.51 | -7.84615384615 | 6.5 | 6.72 | 5.85 | 38285 | 6.03795208 | CS |
4 | -0.33 | -5.22151898734 | 6.32 | 8.0434 | 5.72 | 53199 | 6.46172078 | CS |
12 | 3.87 | 182.547169811 | 2.12 | 8.4399 | 1.96 | 525137 | 5.18561372 | CS |
26 | 3.96 | 195.073891626 | 2.03 | 8.4399 | 1.78 | 241605 | 5.11059144 | CS |
52 | 4.07 | 211.979166667 | 1.92 | 8.4399 | 1.55 | 129305 | 4.94720388 | CS |
156 | 5.592 | 1405.02512563 | 0.398 | 8.4399 | 0.2925 | 100172 | 3.28011784 | CS |
260 | 4.51 | 304.72972973 | 1.48 | 8.4399 | 0.2925 | 460479 | 1.59391395 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions